Fan Hong Hua (Saffron)

Chinese Herb Actions

Chinese Herb Dosage

• What is the typical dosage of Fan Hong Hua (saffron)?

  Our record gives 1.5–6 g (Bensky). That is a small figure by materia medica standards, and roughly half to a third of what is recorded for Hong Hua (safflower), which our site lists at about 3–10 g. Saffron is dosed low for two independent reasons: it is potent at the blood level, and it is the most expensive spice by weight in the world, so gram-scale prescribing is unusual in ordinary practice.

  • Part used — the dried stigmas only, not the whole flower and not the yellow styles or tepals.
  • Preparation — the stigmas are typically steeped or added to a finished decoction rather than boiled hard and long; the colouring and aromatic constituents are heat- and light-sensitive.
  • Modern research doses are not this dose — the clinical trial literature uses standardised saffron capsules or extracts at milligram-scale daily doses, well under 1 g/day; one obstetric trial used 250 mg doses. Those figures describe a manufactured supplement, not a decocted herb, and the two should not be read across.

  Discrepancy noted: reference sources are not unanimous on the upper end of the range. Our record’s 1.5–6 g is at the generous end; a lower range of roughly 1–3 g is commonly given elsewhere for the same drug. We have left our record’s figure unchanged and flag the divergence rather than silently narrowing it.

  Source: our own herb record dosage field and part used; comparison with our Hong Hua record; trial dosing per PMID 28180016, PMC 5285732 and PMID 42186868, PMC 13213103. Reference only — not a prescription and not dosing advice.

Chinese Herb Contraindications & Cautions

• Is Fan Hong Hua (saffron) safe, and can you take it in pregnancy?

  Our record states plainly: do not use during pregnancy. This is the standard contraindication for a strong blood-invigorating herb, and in saffron’s case it is reinforced from outside the tradition — saffron has a long-recorded association with promoting menstruation and uterine contraction, and a 2026 integrative review found that higher intake or occupational exposure has been linked to uterine stimulation and increased miscarriage risk.

  • Pregnancy — contraindicated. The same review notes that low-dose saffron (around 250 mg/day) has been studied at term for cervical ripening under clinical supervision; that is a supervised obstetric setting at the very end of pregnancy and does not soften the general contraindication.
  • Bleeding disorders and anticoagulation — as a blood-invigorating herb, professional supervision is appropriate for anyone with a bleeding tendency, on anticoagulant or antiplatelet medication, or approaching surgery. Precautionary, based on herb category rather than on demonstrated clinical events.
  • Heavy menstrual bleeding — the same reasoning applies to the blood-moving category generally.
  • Reported side effects in trials — a meta-research review of nineteen saffron meta-analyses reported nausea, dry mouth, poor appetite and headache as common, with no serious adverse reactions recorded.
  • Authenticity as a safety issue — because adulterated saffron is common (see notes), what a consumer actually receives may be dyed safflower, turmeric or marigold rather than saffron at all. Product identity matters here more than for almost any other herb on this site.

  Source: our own herb record cautions field; pregnancy evidence per PMID 42186868, PMC 13213103, DOI 10.1177/2515690X261455162 and PMID 28180016, PMC 5285732; tolerability per PMID 34419735, DOI 10.1016/j.phymed.2021.153699. Reference only — not medical advice.

Chinese Herb Toxicity & Overdose

• Low at culinary and normal medicinal amounts; dose-dependent at high amounts. Our record states that overdose can lead to vomiting, intestinal colic, gastrointestinal bleeding, blood in the urine, disorientation and convulsions. These are recorded as reference facts about excessive intake, not as a description of ordinary use — the amounts involved are far above any dose in the dosage section, and in practice saffron’s cost is itself a limiting factor.

  Independent of dose, the practical safety question for saffron is authenticity rather than intrinsic toxicity: adulterants and unauthorised dyes are the more likely source of harm in a commercial sample. A published review of saffron toxicology concludes that saffron is generally regarded as safe, while noting persistent quality variability across sources.

  Source: our own herb record toxicity field; PMID 41462633, PMC 12729493, DOI 10.3390/antiox14121433 (phytochemistry, activities and toxicity overview); PMID 34419735 (adverse-event profile across meta-analyses). Neutral reference information, not a safety guarantee and not usage instructions.

Herb-Drug Interactions

• No well-established clinical herb–drug interactions are documented for Fan Hong Hua, but two areas warrant practitioner awareness. First, antidepressant medication: several randomised trials have compared saffron directly against SSRIs and it has been studied as an add-on to antidepressants, so anyone already taking an antidepressant should treat concurrent saffron supplementation as a matter for their prescriber rather than a self-directed decision. Second, anticoagulant and antiplatelet therapy: this is a blood-invigorating herb, and caution is conventional for the whole category. Both points are precautionary rather than demonstrations of a clinical interaction.

  Source: PMID 38913392, DOI 10.1093/nutrit/nuae076 (saffron versus SSRIs meta-analysis); PMID 34757208, DOI 10.1016/j.phrs.2021.105963 (saffron as adjunct therapy). Flagged for practitioner confirmation; not medical advice.

Western / Biomedical Research

Chinese Herb Clinical Studies & Research

Provided as research context — a summary of published biomedical study, not a therapeutic or medical claim.

• Is there research on saffron (Crocus sativus) for depression?

  Yes — saffron has one of the larger clinical research bases of any herb on this site, with more than thirty randomised trials and multiple meta-analyses, though the quality caveats are substantial. A 2026 GRADE-assessed systematic review pooled 34 randomised controlled trials in 1,769 adults and found that saffron supplementation significantly reduced self-reported depression scores (Beck Depression Inventory, 14 trials, 817 participants, weighted mean difference −4.39) and anxiety scores (Beck Anxiety Inventory, 6 trials, 339 participants, WMD −5.06), with certainty of evidence rated moderate. Critically, it found no significant effect on clinician-rated scales (HDRS, HARS, POMS), and heterogeneity was very high (I² above 90%).

  • Versus antidepressants — a 2025 meta-analysis of eight trials comparing saffron with SSRIs found no significant difference in reduction of depressive symptoms and fewer adverse events in the saffron arms. Non-inferiority in small trials is not the same as demonstrated equivalence.
  • Umbrella analysis — a 2022 umbrella meta-analysis of seven prior meta-analyses found a significant reduction in BDI scores but no significant change in HAMD scores, and concluded saffron cannot be regarded as a stand-alone treatment for depression.
  • Publication bias — a 2019 meta-analysis of 23 trials reported large effect sizes for both depression and anxiety but explicitly noted evidence of publication bias and a lack of regional diversity, with most trials conducted in a single country.
  • Quality of the evidence base — a meta-research review of 19 saffron meta-analyses concluded that the reporting and methodological quality of the published reviews themselves needs improvement, and that effects need confirmation in large multi-country trials.
  • Guideline status — saffron is among the phytoceuticals assessed in the 2022 WFSBP/CANMAT international clinician guidelines for nutraceuticals and phytoceuticals in psychiatry.

  The essential caveat. These trials studied standardised saffron capsules and extracts at milligram daily doses, taken alone as a single agent for a biomedical diagnosis. They did not study Fan Hong Hua as it is used in Chinese medicine — a gram-scale crude drug inside a multi-herb formula, prescribed on a pattern rather than a diagnosis. This is the same distinction we apply to Chuan Xin Lian and Sang Zhi: the research is genuine and it is about the same plant, but it is not evidence about the traditional preparation.

  Other research areas. Saffron’s principal constituents are crocin, crocetin, picrocrocin and safranal. Meta-analyses have also examined effects on fasting blood glucose, waist circumference, blood pressure and blood lipids, and a separate meta-analysis has looked at mild cognitive impairment and dementia. None of this constitutes a treatment claim.

  Sources: PMID 41693488, DOI 10.1080/1028415X.2025.2602153 (GRADE meta-analysis, 34 RCTs); PMID 38913392, DOI 10.1093/nutrit/nuae076 (saffron vs SSRIs); PMID 34757208, DOI 10.1016/j.phrs.2021.105963 (umbrella meta-analysis); PMID 31135916, DOI 10.1093/nutrit/nuz023 (23-trial meta-analysis, publication bias); PMID 32221179, DOI 10.1097/NMD.0000000000001118; PMID 34419735, DOI 10.1016/j.phymed.2021.153699 (meta-research review); PMID 35311615, DOI 10.1080/15622975.2021.2013041 (WFSBP/CANMAT guidelines); PMID 33167948, PMC 7650148 (cognition); PMID 41462633, PMC 12729493 (phytochemistry). Research context only — not a therapeutic claim.

Chinese Herb Notes

• What is the difference between Fan Hong Hua (saffron) and Hong Hua (safflower)?

  They are two entirely different plants from two different families, and confusing them is the single most consequential naming error on this part of the materia medica. Fan Hong Hua is Crocus sativus, an iris relative, and the drug is the flower’s three red stigmas. Hong Hua — which we hold under the Latin Flos Carthami Tinctorii — is safflower, a thistle-like daisy relative, and the drug is the whole floret. One is the most expensive spice in the world; the other is a cheap bulk crop grown mainly for oil and dye.

  • Botany — Crocus sativus (Iridaceae) versus Carthamus tinctorius (Asteraceae). Not close relatives, not substitutes.
  • Part used — three hand-picked stigmas per crocus flower, versus the whole safflower floret.
  • Shared ground — our site places both in the same category (herbs that invigorate blood and remove stagnation) and gives both the Heart and Liver channels. Both unblock the menses and move blood stasis.
  • Where they part — Fan Hong Hua additionally cools the blood and resolves toxicity, and is used for feverish rashes; Hong Hua has no such blood-cooling indication and is instead the everyday choice for trauma, fixed pain and gynaecological stasis.
  • Cost and dose — saffron is dosed in the low grams and safflower in the mid single-to-double grams; the price gap between them runs to two or three orders of magnitude.

  Why is saffron called “Fan” Hong Hua, and what does “Zang Hong Hua” mean?

  The prefix fān (番) is the Chinese marker historically attached to plants that arrived from abroad — the same prefix carried by Fan Xie Ye (senna), which we also hold. The name records, in the drug’s own title, that saffron is not native to China. It reached China along the western trade routes from Persia and India, and it enters the Chinese materia medica late rather than descending from the early classics.

  • The Tibet confusion — our record carries the alternate name Zang Hong Hua (藏红花, “Tibetan red flower”) and the Chinese characters 藏红花. Saffron is not a Tibetan crop. The name is a route name, not an origin name: the material historically entered China by way of Tibet and the Himalayan trade, and the label stuck. A third name, Xi Hong Hua (“western red flower”), records the same fact more accurately.
  • Parallel with Fan Xie Ye — senna is the other clear case on this site of an imported drug whose foreignness is preserved in its Chinese name. Both are useful reminders that the Chinese materia medica has always absorbed material from outside China.

  Identity note flagged for review (not changed): our record lists the properties as Spicy, Warm. That is the profile normally given for Hong Hua (safflower); published references more commonly describe Fan Hong Hua as sweet and cool to neutral. Our record’s translation field, “Tibetan Red Flower,” also renders the alternate name Zang Hong Hua rather than the headword Fan Hong Hua, which means “foreign red flower.” Both are left unchanged pending owner confirmation.

  Is saffron really the most adulterated spice in the world?

  Its price makes it one of the most persistently faked commodities in the food supply, and there is a large analytical literature devoted to catching the fakes. Published work has developed DNA barcoding, real-time PCR, NMR fingerprinting, infrared and fluorescence spectroscopy, high-resolution mass spectrometry and thin-layer chromatography specifically to detect saffron adulteration — a body of method development that exists because the problem is real and commercially significant.

  • Documented botanical adulterants — a 2023 study developed detection for safflower, calendula (marigold), turmeric, achiote, red pepper, mountain arnica, beet and pomegranate, at added levels as low as 1% by weight.
  • Safflower again — the commonest look-alike substitution is the very herb readers confuse it with. A dedicated real-time PCR method can quantify Carthamus tinctorius in saffron down to 0.1%.
  • How bad it gets — a Kashmiri market survey found only 40% of samples met ISO Category I, with an average adulteration of about 36% in the remainder.
  • What we are not claiming — various colourful adulterants circulate in popular accounts. We report only those documented in the analytical literature above.

  Source: our own Fan Hong Hua and Hong Hua herb records (Latin names, category, channels, dosage); our Fan Xie Ye record for the 番 prefix parallel; adulteration findings per PMID 37587313, PMC 10474180, DOI 10.1007/s00216-023-04853-x; PMID 28372231, DOI 10.1016/j.foodchem.2017.02.136; PMID 36035668, PMC 9417335, DOI 10.3389/fpls.2022.945291; PMID 38144850, PMC 10740065. Naming history cross-referenced against multiple online sources.